COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,058 | -12.4% | 106,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $455,609 | -37.6% | 106,700 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $729,828 | -13.6% | 106,700 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $845,064 | -19.5% | 106,700 | -2.4% | 0.01% | -25.0% |
| Q3 2022 | $1,050,000 | +19.0% | 109,277 | -10.3% | 0.01% | +33.3% |
| Q2 2022 | $882,000 | -52.2% | 121,784 | -14.8% | 0.01% | -43.8% |
| Q1 2022 | $1,845,000 | +137.8% | 142,947 | +194.0% | 0.02% | +166.7% |
| Q4 2021 | $776,000 | -67.2% | 48,629 | -66.9% | 0.01% | -66.7% |
| Q3 2021 | $2,363,000 | +32.8% | 147,023 | +14.3% | 0.02% | +50.0% |
| Q2 2021 | $1,779,000 | -4.5% | 128,637 | +0.9% | 0.01% | -7.7% |
| Q1 2021 | $1,862,000 | -68.5% | 127,473 | -62.6% | 0.01% | -73.5% |
| Q4 2020 | $5,917,000 | -12.9% | 340,472 | -8.1% | 0.05% | -32.9% |
| Q3 2020 | $6,795,000 | +7.0% | 370,514 | +4.2% | 0.07% | +4.3% |
| Q2 2020 | $6,351,000 | +31.2% | 355,615 | +19.1% | 0.07% | +6.1% |
| Q1 2020 | $4,842,000 | – | 298,512 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |